About Novastep
Novastep is a company based in New York (United States) founded in 2019 was acquired by Enovis in April 2023. It operates as a Direct-to-Consumer (D2C) and Professional Services. Novastep offers products and services including Pecaplasty System, Centrolock System, Airlock Plating System, Lync Hammertoe Correction, and Arcad Nitinol Compression Staples. Novastep operates in a competitive market with competitors including Toetal Solutions, DT MedTech, SelectFlex, AlphaMet and Panther Orthopedics, among others.
- Headquarter New York, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Novastep Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Novastep
Novastep offers a comprehensive portfolio of products and services, including Pecaplasty System, Centrolock System, Airlock Plating System, Lync Hammertoe Correction, and Arcad Nitinol Compression Staples.
Minimally invasive bunion correction system is provided.
Guided transverse osteotomy for hallux valgus correction.
Forefoot and midfoot plating system is offered.
Hammertoe fixation solution is designed for correction.
Compression staples made of nitinol are provided.
Funding Insights of Novastep
Detailed funding history for Novastep
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Novastep
Novastep has secured backing from 1 investor. Prominent investors backing the company include Enovis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Medical devices for bracing, surgery, and recovery are manufactured.
|
Locked | Locked | Locked |
Investor details for Novastep
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Novastep
Investment portfolio details for Novastep
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Novastep
Detailed financials for Novastep
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Novastep Comparisons
Peer comparison for Novastep
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Novastep
Novastep operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Toetal Solutions, DT MedTech, SelectFlex, AlphaMet and Panther Orthopedics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Platform solutions for foot and ankle deformities are provided.
|
|
| Locked | Locked | Locked |
Instruments for joint implantation and reconstruction are manufactured.
|
|
| Locked | Locked | Locked |
Offers adjustable insoles for foot pain relief and arch support.
|
|
| Locked | Locked | Locked |
Develops and markets innovative implants and instruments for minimal invasive foot surgery.
|
|
| Locked | Locked | Locked |
Creates innovative superelastic fixation devices for treating ankle syndesmosis conditions.
|
Detailed competitors of Novastep
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Novastep
Complete news archive for Novastep
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Novastep
Novastep was founded in 2019.
Novastep is headquartered in New York, United States. It is registered at New York, New York, United States.
Vadim Gurevich is the current CEO of Novastep.
Novastep is established as a key player in the foot and ankle medical device sector. The company is focused on delivering innovative solutions for minimally invasive surgeries, particularly for bunion and hammertoe corrections. Products such as the Pecaplasty System and Centrolock System are developed to address clinical challenges and improve outcomes. Solutions are tailored for ambulatory surgery centers, emphasizing cost-effectiveness and enhanced delivery experiences. Novastep operates primarily in the United States while maintaining an international presence.
Novastep's top competitors include DT MedTech, Toetal Solutions and SelectFlex.
Novastep offers Pecaplasty System, Centrolock System, Airlock Plating System, Lync Hammertoe Correction, and Arcad Nitinol Compression Staples.
Novastep has 1 investor. Key investors include Enovis.